Home/Switch Therapeutics/Charles Allerson, PhD
CA

Charles Allerson, PhD

Chief Technology Officer

Switch Therapeutics

Switch Therapeutics Pipeline

DrugIndicationPhase
Undisclosed CNS PipelineCentral Nervous System DiseasesPre-clinical